We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$245M
AUM Growth
+$18.2M
Cap. Flow
+$2.74M
Cap. Flow %
1.12%
Top 10 Hldgs %
66.41%
Holding
667
New
60
Increased
182
Reduced
81
Closed
82

Top Buys

Rank Stock Value
1
AXGN icon
Axogen
AXGN
+$3.91M
2
SIBN icon
SI-BONE Inc
SIBN
+$2.35M
3
NEO icon
NeoGenomics
NEO
+$1.8M
4
MASS icon
908 Devices
MASS
+$1.68M
5
HCAT icon
Health Catalyst
HCAT
+$1.18M

Top Sells

Rank Stock Value
1
PHLT
Performant Healthcare Inc
PHLT
+$5.84M
2
ANAB icon
AnaptysBio
ANAB
+$1.6M
3
INSM icon
Insmed
INSM
+$1M
4
ATEC icon
Alphatec Holdings
ATEC
+$740K
5
WFC icon
Wells Fargo
WFC
+$539K

Sector Composition

Rank Sector Weight
1 Healthcare 22.08%
2 Financials 4.47%
3 Technology 3.55%
4 Industrials 1.31%
5 Consumer Discretionary 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBRX icon
576
ImmunityBio
IBRX
$7.8B
$79 ﹤0.01%
40
– –
CHPT icon
577
ChargePoint
CHPT
$142M
$73 ﹤0.01%
11
– –
BYND icon
578
Beyond Meat
BYND
$286M
$53 ﹤0.01%
65
-5,000
-99% -$6.95K
CGC
579
Canopy Growth
CGC
$388M
$34 ﹤0.01%
30
-100
-77% -$129
WW
580
WW International
WW
$139M
$29 ﹤0.01%
1
– –
XFOR icon
581
X4 Pharmaceuticals
XFOR
$377M
$24 ﹤0.01%
6
– –
GNPX icon
582
Genprex
GNPX
$3.06M
– –
0
– –
AQB icon
583
AquaBounty Technologies
AQB
$4.68M
$9 ﹤0.01%
10
– –
ICU icon
584
SeaStar Medical
ICU
$12.7M
$4 ﹤0.01%
2
– –
PTEN icon
585
Patterson-UTI
PTEN
$3.74B
$4 ﹤0.01%
1
– –
ADAP
586
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-287
Closed -$37
ADMA icon
587
ADMA Biologics
ADMA
$2.01B
– –
-885
Closed -$13K
AER icon
588
AerCap
AER
$24.1B
– –
-41
Closed -$4.96K
AJG icon
589
Arthur J. Gallagher & Co
AJG
$65.9B
– –
-21
Closed -$6.5K
ANGO icon
590
AngioDynamics
ANGO
$610M
– –
-4,500
Closed -$50.3K
AQMS icon
591
Aqua Metals
AQMS
$10.2M
– –
-100
Closed -$640
BKR icon
592
Baker Hughes
BKR
$59.5B
– –
-103
Closed -$5.02K
BOC icon
593
Boston Omaha
BOC
$425M
– –
-1,500
Closed -$19.6K
BTG icon
594
B2Gold
BTG
$5.13B
– –
-419
Closed -$2.07K
BVS icon
595
Bioventus
BVS
$893M
– –
-1,500
Closed -$10K
CCEP icon
596
Coca-Cola Europacific Partners
CCEP
$49.3B
– –
-41
Closed -$3.74K
CGNT icon
597
Cognyte Software
CGNT
$647M
– –
-138
Closed -$1.16K
CLOU icon
598
Global X Cloud Computing ETF
CLOU
$237M
– –
-25
Closed -$579
CLS icon
599
Celestica
CLS
$40.5B
– –
-11
Closed -$2.71K
CLX icon
600
Clorox
CLX
$11.7B
– –
-64
Closed -$7.89K
22 23
24
25 26

Similar funds

IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return
SVWG
Shared Vision Wealth Group Carlsbad, United States $245M AUM 15.52% 1-Year Est. Return

HighMark Wealth Management's Q4 2025 Portfolio in Review

As of Q4 2025, HighMark Wealth Management held 667 positions worth $245M, up 8% from $227M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HighMark Wealth Management's Q4 2025 filing shows 60 new, 182 increased, 81 reduced and 82 closed positions. Its largest new stake was 908 Devices: 241,000 shares worth $1.27M. The largest sale was Performant Healthcare Inc, an estimated $5.84M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q4 2025 buy was 908 Devices: 241,000 shares worth $1.27M.
  • HighMark Wealth Management added most to Axogen in Q4 2025, an estimated $3.91M increase.
  • HighMark Wealth Management's biggest Q4 2025 reduction was AnaptysBio, cutting an estimated $1.6M.
  • HighMark Wealth Management fully exited Performant Healthcare Inc in Q4 2025, selling an estimated $5.84M.
  • HighMark Wealth Management's ten largest holdings make up 66% of its $245M portfolio in Q4 2025.
  • HighMark Wealth Management opened 60 new positions and closed 82 in Q4 2025.
  • HighMark Wealth Management's portfolio value rose 8% quarter-over-quarter to $245M.

Based on HighMark Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.